Mizuta H - Search Results

1

Primary Cutaneous Rosai-Dorfman Disease of the Scalp.

Mizuta H, Nakano E, Yamazaki N. Mizuta H, et al. Dermatol Pract Concept. 2020 Dec 7;11(1):e2020086. doi: 10.5826/dpc.1101a86. eCollection 2021 Jan. Dermatol Pract Concept. 2020. PMID: 33354400 Free PMC article. No abstract available.

2

Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study.

Namikawa K, Takahashi A, Mori T, Tsutsumida A, Suzuki S, Motoi N, Jinnai S, Kage Y, Mizuta H, Muto Y, Nakano E, Yamazaki N. Namikawa K, et al. Among authors: mizuta h. Melanoma Res. 2020 Feb;30(1):76-84. doi: 10.1097/CMR.0000000000000617. Melanoma Res. 2020. PMID: 31095037

3

Efficacy of oral retinoids for keratoacanthoma centrifugum marginatum.

Mizuta H, Takahashi A, Mori T, Namikawa K, Nakano E, Muto Y, Jinnai S, Nakama K, Tsutsui K, Yamazaki N. Mizuta H, et al. Dermatol Ther. 2020 May;33(3):e13291. doi: 10.1111/dth.13291. Epub 2020 Mar 14. Dermatol Ther. 2020. PMID: 32125740

4

Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.

Tsutsui K, Takahashi A, Muto Y, Mizuta H, Jinnai S, Nakama K, Ogata D, Namikawa K, Yamazaki N. Tsutsui K, et al. Among authors: mizuta h. J Dermatol. 2020 May;47(5):512-517. doi: 10.1111/1346-8138.15285. Epub 2020 Mar 10. J Dermatol. 2020. PMID: 32157716

5

Correlation between cutaneous adverse events and prognosis in patients with melanoma treated with nivolumab: A single institutional retrospective study.

Nakano E, Takahashi A, Namikawa K, Muto Y, Jinnai S, Kage Y, Mizuta H, Tsutsumida A, Yamazaki N. Nakano E, et al. Among authors: mizuta h. J Dermatol. 2020 Jun;47(6):622-628. doi: 10.1111/1346-8138.15309. Epub 2020 Mar 11. J Dermatol. 2020. PMID: 32162349

6

Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review.

Mizuta H, Nakano E, Takahashi A, Koyama T, Namikawa K, Yamazaki N. Mizuta H, et al. Dermatol Ther. 2020 May;33(3):e13321. doi: 10.1111/dth.13321. Epub 2020 Mar 25. Dermatol Ther. 2020. PMID: 32191382 Review.

7

Association between prognosis and complete resection in primary cutaneous myoepithelial carcinoma: two case presentations and literature review.

Mizuta H, Takahashi A, Namikawa K, Ogata D, Yamazaki N. Mizuta H, et al. Dermatol Ther. 2020 Jul;33(4):e13485. doi: 10.1111/dth.13485. Epub 2020 Jun 2. Dermatol Ther. 2020. PMID: 32369232 Review.

8

The first case of a collision tumor of melanotrichoblastoma and seborrheic keratosis.

Mizuta H, Namikawa K, Takahashi A, Ogata D, Muto Y, Jinnai S, Nakama K, Tsutsui K, Yamazaki N. Mizuta H, et al. Int J Dermatol. 2021 Feb;60(2):e54-e56. doi: 10.1111/ijd.15042. Epub 2020 Jul 8. Int J Dermatol. 2021. PMID: 32643154 No abstract available.

9

Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.

Takahashi A, Namikawa K, Ogata D, Nakano E, Jinnai S, Nakama K, Tsutsui K, Muto Y, Mizuta H, Yamazaki N. Takahashi A, et al. Among authors: mizuta h. J Dermatol. 2020 Nov;47(11):1267-1275. doi: 10.1111/1346-8138.15521. Epub 2020 Jul 28. J Dermatol. 2020. PMID: 32725685 Clinical Trial.

10

Intramedullary spinal cord metastasis of malignant melanoma:Two cases with rim signs in contrast-enhanced magnetic resonance imaging: A case report.

Mizuta H, Namikawa K, Nakama K, Yamazaki N. Mizuta H, et al. Mol Clin Oncol. 2021 Mar;14(3):47. doi: 10.3892/mco.2021.2209. Epub 2021 Jan 14. Mol Clin Oncol. 2021. PMID: 33575031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters